Treatmentof various forms oftuberculosisis complex, using medicines ofdifferent pharmacotherapeuticgroups. But avery important is theethiotropictreatmentwithantiTB drugs, divided in some groups:Hydrazides, antibiotics, p-aminosalicylicacid derivatives, tiocarbamides,butanolderivates. Purpose: evaluation of the arsenal of drugs used to treat tuberculosis in Moldova. Material and Methods: analysis of the State List of RM drugs as well, recommendations of the WHO and specialists in the field; statistical data processing. Results: According to the international classification ATC, the Collaborating Centrefor Statistical Methodology WHO recordedon 02/25/2013, in the J04Agroup, 17single international common name sand 6TB drug combinations. On the RMpharmaceuticalmarketcurrently 29 names of tuberculos is remediesare found, including eightinternationalcommon names, that means 47% ofthose recordedby WHO.Hydrazidesgroupcontaining 50% of all those recommendedby WHO, antibiotics -33.3%, salicylates -67%; the thiocarbamides group is not registering any records, other remedies- 50%. Combine dantituberculosisdrugsareabout 17%. Only onedrug ismade in RM (Isoniazid comp. 300 and 100mg and sol. Injection100mg/ ml), the rest being imported. Conclusions: Taking in consideration the rapid development of resistance to Mycobacterium tuberculosis, development of new drugs of this group and their implementation in the current production in RM is very actual in order to make sure that the population has a full access at a big variety of antimycobacterial medicines.